Demirović Alma, Tomas Davor, Tomić Karla, Spajić Borislav, Ibukić Amir, Cupić Hrvoje, Krušlin Božo
University Department of Pathology and Departments of.
Scand J Urol. 2014 Feb;48(1):34-40. doi: 10.3109/21681805.2013.828319. Epub 2013 Nov 21.
The aim of this study was to correlate the expression of vascular endothelial growth factor (VEGF) and hypoxia-inducible factor-1α (HIF-1α) with pathological renal artery changes in patients with renal cell carcinoma (RCC). A further aim was to correlate intratumoral microvessel density (MVD) with VEGF and HIF-1α expression and prognostic factors for RCC, including tumour necrosis.
Formalin-fixed and paraffin-embedded tissue blocks from 150 patients with RCC and 50 patients with non-tumorous kidney diseases were analysed. The control group consisted of specimens from both renal arteries obtained from 25 decedents at routine autopsy (50 cases in total). Immunohistochemistry was performed using primary antibodies to VEGF, HIF-1α and CD31.
Pathological renal artery changes were more common in patients with RCC and non-tumorous kidney diseases than in the control group. MVD was higher in the RCCs of patients with pathological renal artery changes. Tumours with higher HIF-1α expression had higher MVD; however, VEGF expression was not associated with MVD. A significant association was also found between MVD and the extent of tumour necrosis, in that less necrotic tumours had higher MVD. No association between renal artery changes and VEGF and HIF-1α expression was established.
Considering the results of this study, the evaluation of renal artery changes in forthcoming research on RCC would be helpful for several reasons: to estimate their incidence in a larger number of patients, to clarify their connection with RCC and to reveal their relationship with MVD in RCC.
本研究旨在探讨血管内皮生长因子(VEGF)和缺氧诱导因子-1α(HIF-1α)的表达与肾细胞癌(RCC)患者肾动脉病理改变之间的相关性。另一个目的是研究肿瘤内微血管密度(MVD)与VEGF和HIF-1α表达以及RCC预后因素(包括肿瘤坏死)之间的相关性。
分析了150例RCC患者和50例非肿瘤性肾脏疾病患者的福尔马林固定石蜡包埋组织块。对照组由25例死者尸检时获取的双侧肾动脉标本组成(共50例)。采用VEGF、HIF-1α和CD31的一抗进行免疫组织化学检测。
RCC和非肿瘤性肾脏疾病患者的肾动脉病理改变比对照组更为常见。有肾动脉病理改变的RCC患者的MVD更高。HIF-1α表达较高的肿瘤MVD也较高;然而,VEGF表达与MVD无关。MVD与肿瘤坏死程度之间也存在显著相关性,即坏死程度较轻的肿瘤MVD较高。未发现肾动脉改变与VEGF和HIF-1α表达之间存在关联。
基于本研究结果,在未来的RCC研究中评估肾动脉改变将有帮助,原因如下:估计其在更多患者中的发生率,阐明其与RCC的联系,并揭示其与RCC中MVD的关系。